Aktive Positionen von Brooks Rahmer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Investor Relations Kontakt | - | - |
Karriereverlauf von Brooks Rahmer
Ehemalige bekannte Positionen von Brooks Rahmer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MYOKARDIA, INC. | Investor Relations Kontakt | 01.05.2019 | 01.01.2021 |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Investor Relations Contact | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Brooks Rahmer
- Erfahrung
